CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 124 filers reported holding CARA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,632 | -59.2% | 30,733 | -31.3% | 0.00% | – |
| Q2 2023 | $126,549 | -35.4% | 44,717 | +12.1% | 0.00% | – |
| Q1 2023 | $195,805 | -47.9% | 39,879 | +14.0% | 0.00% | – |
| Q4 2022 | $375,556 | -40.0% | 34,968 | -47.7% | 0.00% | – |
| Q3 2022 | $626,000 | -3.2% | 66,848 | -5.8% | 0.00% | – |
| Q2 2022 | $647,000 | -52.4% | 70,951 | -36.5% | 0.00% | – |
| Q1 2022 | $1,358,000 | -16.1% | 111,709 | -15.9% | 0.00% | – |
| Q4 2021 | $1,618,000 | -44.1% | 132,793 | -29.1% | 0.00% | -100.0% |
| Q3 2021 | $2,894,000 | -9.4% | 187,335 | -16.3% | 0.00% | 0.0% |
| Q2 2021 | $3,194,000 | +1.1% | 223,861 | +53.8% | 0.00% | 0.0% |
| Q1 2021 | $3,160,000 | +64.8% | 145,577 | +14.9% | 0.00% | – |
| Q4 2020 | $1,917,000 | +39.6% | 126,688 | +17.4% | 0.00% | – |
| Q3 2020 | $1,373,000 | -32.7% | 107,890 | -9.5% | 0.00% | -100.0% |
| Q2 2020 | $2,039,000 | +47.6% | 119,193 | +14.0% | 0.00% | – |
| Q1 2020 | $1,381,000 | -15.8% | 104,575 | +2.6% | 0.00% | – |
| Q4 2019 | $1,641,000 | -38.0% | 101,877 | -29.6% | 0.00% | -100.0% |
| Q3 2019 | $2,646,000 | -22.3% | 144,730 | -8.6% | 0.00% | 0.0% |
| Q2 2019 | $3,405,000 | +58.9% | 158,368 | +45.0% | 0.00% | 0.0% |
| Q1 2019 | $2,143,000 | +48.0% | 109,226 | -1.9% | 0.00% | – |
| Q4 2018 | $1,448,000 | -46.1% | 111,362 | -0.6% | 0.00% | -100.0% |
| Q3 2018 | $2,684,000 | +57.6% | 112,079 | +26.0% | 0.00% | 0.0% |
| Q2 2018 | $1,703,000 | +62.3% | 88,949 | +5.0% | 0.00% | – |
| Q1 2018 | $1,049,000 | +326.4% | 84,697 | +322.5% | 0.00% | – |
| Q4 2017 | $246,000 | -36.1% | 20,046 | -28.7% | 0.00% | – |
| Q3 2017 | $385,000 | -17.2% | 28,124 | -6.7% | 0.00% | – |
| Q2 2017 | $465,000 | -17.4% | 30,136 | -1.7% | 0.00% | – |
| Q1 2017 | $563,000 | +152.5% | 30,664 | +28.0% | 0.00% | – |
| Q4 2016 | $223,000 | +123.0% | 23,951 | +99.5% | 0.00% | – |
| Q3 2016 | $100,000 | +284.6% | 12,007 | +127.2% | 0.00% | – |
| Q2 2016 | $26,000 | -65.8% | 5,285 | -56.1% | 0.00% | – |
| Q1 2016 | $76,000 | -57.8% | 12,044 | +12.5% | 0.00% | – |
| Q4 2015 | $180,000 | +91.5% | 10,706 | +62.6% | 0.00% | – |
| Q3 2015 | $94,000 | -17.5% | 6,586 | -29.6% | 0.00% | – |
| Q2 2015 | $114,000 | +1800.0% | 9,360 | +1434.4% | 0.00% | – |
| Q1 2015 | $6,000 | +200.0% | 610 | +144.0% | 0.00% | – |
| Q4 2014 | $2,000 | 0.0% | 250 | +0.8% | 0.00% | – |
| Q3 2014 | $2,000 | -75.0% | 248 | -42.2% | 0.00% | – |
| Q2 2014 | $8,000 | -91.8% | 429 | -91.8% | 0.00% | – |
| Q1 2014 | $97,000 | – | 5,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |